People: Infinity Pharmaceuticals Inc (INFI.O)

INFI.O on Nasdaq

5.63USD
1:00pm EST
Change (% chg)

$0.07 (+1.26%)
Prev Close
$5.56
Open
$5.65
Day's High
$5.91
Day's Low
$5.32
Volume
126,829
Avg. Vol
938,961
52-wk High
$16.98
52-wk Low
$5.24

Search Stocks

Perkins, Adelene 

Ms. Adelene Q. Perkins is Chairman of the Board, President, Chief Executive Officer of Infinity Pharmaceuticals Inc. She has served as a member of board of directors and President and Chief Executive Officer since January 2010, including as chair of board of directors since November 2012, as President and Chief Business Officer from October 2008 through December 2009 and as Executive Vice President and Chief Business Officer between September 2006 and October 2008. Ms. Perkins served as Executive Vice President and Chief Business Officer between September 2006 and October 2008. Ms. Perkins served as Executive Vice President of IPI from February 2006 until its merger with DPI in September 2006 and Chief Business Officer of IPI from June 2002 until the DPI merger. Prior to joining IPI, Ms. Perkins served as Vice President of Business and Corporate Development of TransForm Pharmaceuticals, Inc., a private pharmaceutical company, from 2000 to 2002. From 1992 to 1999, Ms. Perkins held various positions at Genetics Institute, most recently serving as Vice President of Emerging Business and General Manager of the DiscoverEase® business unit. From 1985 to 1992, Ms. Perkins held a variety of positions at Bain & Company, a strategy consulting firm. Ms. Perkins received a B.S. in Chemical Engineering from Villanova University and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 938,025
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 697,454
Fiscal Year Total, USD 1,635,480

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks